|
Printable version |
From: | Derek <dkw@paradise.net.nz> |
Date: | Wed, 24 Apr 2002 20:50:23 +1200 |
Quote from SharesWeekly, beginning of March 2002, note the last sentence. "Last month Peptech finally received the news everyone was waiting for. The US Patent Office granted Peptech a "notice of allowance" for its TNF antibody patent in the US. This means companies with TNF antibody drugs on the market, such as Centocor, and companies with TNF antibody drugs in development, such as Abbot Laboratories, will be required to pay Peptech royalties for the next 11 years. What is also good news for Peptech is that it has already settled with these two groups. The patent is a divisional patent and is not as broad as that granted in Europe. This means companies such as Immunex, which has developed TNF drugs that are not complete antibodies, are not covered under this divisional patent. However, Peptech is looking to submit additional divisional patent applications in the US to broaden cover to all TNF drugs, although the possibility of this being granted is remote." Actually I think that PTD could be good buying soon, The Abbot drug looks like be a real winner and if PTD does miss out on patents that cover Immunex's 'Enbrel' etc it may not be the end of the world. My only misgiving is related to the immune suppression that these anti-TNF drugs have, I can't help wonder if their long term use will see an increase in cancer in users. clinical trials are all very well, but they may not run long enough to pick up such an effect. To date however there are no statistics to suggest a problem, see http://www.cnn.com/2001/HEALTH/conditions/08/17/arthritis.drug.safety/ But there is this - "The FDA did, however, tell Immunex to study Enbrel's long-term effects, in case it affects the immune system enough to increase patients' risk of infections or possibly even cancer." (from http://acmi.canoe.ca/HealthNews/981103_arthritis.html ) Time will tell, Regards, Derek disc. Not currently holding PTD ---------------------------------------------------------------------------- To remove yourself from this list, please use the form at http://www.sharechat.co.nz/chat/forum/
Replies
|